MRNA vs GILD: Which Stock is Better?
Side-by-side comparison of Moderna Inc and Gilead Sciences Inc in 2026
MRNA
Moderna Inc
$53.57
GILD
Gilead Sciences Inc
$148.95
Key Metrics Comparison
| Metric | MRNA | GILD | Winner |
|---|---|---|---|
| Market Cap | $20.93B | $184.91B | GILD |
| P/E Ratio | N/A | 21.97 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -0.3% | 0.0% | GILD |
| Gross Margin | -105.8% | 78.8% | GILD |
Analyze MRNA
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MRNA or GILD a better investment?
Comparing MRNA and GILD: Moderna Inc has a market cap of $20.93B while Gilead Sciences Inc has $184.91B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MRNA and GILD?
MRNA (Moderna Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MRNA or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MRNA or GILD?
GILD has higher revenue growth at 0.0% vs -0.3% for MRNA.
Which company is more profitable: MRNA or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to -105.8% for MRNA.
Which is the larger company: MRNA or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $184.91B compared to $20.93B for MRNA.
Should I buy MRNA or GILD in 2026?
Both MRNA and GILD have investment merit. MRNA trades at $53.57 while GILD trades at $148.95. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MRNA and GILD stock?
Key differences: Market Cap ($20.93B vs $184.91B), P/E Ratio (N/A vs 22.0x), Revenue Growth (-0.3% vs 0.0%), Gross Margin (-105.8% vs 78.8%).